ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET


Faron Pharma. Oy.
223 announcements.
Time Ticker Company Announcement
07:30 FARN Faron Pharmaceuticals Oy
To Participate in Upcoming Investor Conferences
07:00 FARN Faron Pharmaceuticals Oy
Bexmarilimab (Clevegen) development update
07:00 FARN Faron Pharmaceuticals Oy
Issue of Equity
11:35 FARN Faron Pharmaceuticals Oy
First Results from WHO Solidarity Trial
14:15 FARN Faron Pharmaceuticals Oy
Grant of options
07:15 FARN Faron Pharma. Oy
Exercise of options
07:00 FARN Faron Pharma. Oy
Half-year Report
07:00 FARN Faron Pharma. Oy
MATINS trial data presented at ESMO
12:00 FARN Faron Pharma. Oy
Faron to Present at H.C. Wainwright Conference
07:00 FARN Faron Pharma. Oy
Notice of Half-Year Report
07:00 FARN Faron Pharma. Oy
Traumakine Update
16:41 FARN Faron Pharma. Oy
Second Price Monitoring Extn
16:36 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
Change of Adviser
16:41 FARN Faron Pharma. Oy
Second Price Monitoring Extn
16:35 FARN Faron Pharma. Oy
Price Monitoring Extension
15:00 FARN Faron Pharma. Oy
Managers' transactions
07:00 FARN Faron Pharma. Oy
Faron update on pipeline progress ahead of R&D Day
07:01 FARN Faron Pharma. Oy
Faron hosts virtual R&D Day today
07:00 FARN Faron Pharma. Oy
Faron receives EUR 2.1 million funding from BF
07:00 FARN Faron Pharma. Oy
Faron selected for EUR2.5 million grant from EIC
07:00 FARN Faron Pharma. Oy
MATINS Update
07:00 FARN Faron Pharma. Oy
Faron announces R&D Day to be held in June
07:00 FARN Faron Pharma. Oy
Publication in Intensive Care Medicine
16:00 FARN Faron Pharma. Oy
Results of the Annual General Meeting
13:00 FARN Faron Pharma. Oy
Exercise of options
10:00 FARN Faron Pharma. Oy
Faron receives grant from Business Finland
07:00 FARN Faron Pharma. Oy
Clevegen manufacturing agreement
13:15 FARN Faron Pharma. Oy
Holding(s) in Company
14:45 FARN Faron Pharma. Oy
Holding(s) in Company
07:00 FARN Faron Pharma. Oy
Traumakine to be a part of WHO's Solidarity trial
13:00 FARN Faron Pharma. Oy
Update on results of Placing and issue of equity
07:00 FARN Faron Pharma. Oy
Result of placing and issue price
16:45 FARN Faron Pharma. Oy
Proposed Placing
11:06 FARN Faron Pharma. Oy
Second Price Monitoring Extn
11:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
Notice of Annual General Meeting
14:45 FARN Faron Pharma. Oy
AGM to be postponed
07:00 FARN Faron Pharma. Oy
REMAP-CAP to study IFN beta-1a effect in COVID-19
07:00 FARN Faron Pharma. Oy
Part 1 of the MATINS Phase I/II Study Completed
10:00 FARN Faron Pharma. Oy
Correction to Faron�s Annual Report 2019
07:28 FARN Faron Pharma. Oy
Faron�s Annual Report 2019 published
11:30 FARN Faron Pharma. Oy
Notice of Annual General Meeting
07:00 FARN Faron Pharma. Oy
Final Results for the year ended December 31, 2019
16:41 FARN Faron Pharma. Oy
Second Price Monitoring Extn
16:36 FARN Faron Pharma. Oy
Price Monitoring Extension
16:44 FARN Faron Pharma. Oy
Second Price Monitoring Extn
16:38 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
FDA accepts protocol for new Traumakine trial
07:00 FARN Faron Pharma. Oy
MATINS update
07:00 FARN Faron Pharma. Oy
Faron to acquire AOC3 antagonist platform
07:01 FARN Faron Pharma. Oy
Second Price Monitoring Extn
07:05 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
Price Monitoring Extension
14:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
11:00 FARN Faron Pharma. Oy
Price Monitoring Extension
16:41 FARN Faron Pharma. Oy
Second Price Monitoring Extn
16:35 FARN Faron Pharma. Oy
Price Monitoring Extension
11:06 FARN Faron Pharma. Oy
Second Price Monitoring Extn
11:00 FARN Faron Pharma. Oy
Price Monitoring Extension
09:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
09:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
Traumakine update
07:00 FARN Faron Pharma. Oy
Ovarian cancer selected as 2nd MATINS trial cohort
07:00 FARN Faron Pharma. Oy
DMC approves colorectal cancer cohort expansion
09:30 FARN Faron Pharma. Oy
Update on Traumakine drug substance manufacturing
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
Matins Trial Update
14:06 FARN Faron Pharma. Oy
Second Price Monitoring Extn
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
14:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:31 FARN Faron Pharma. Oy
LIQUIDITY PROVIDING AGREEMENT
07:30 FARN Faron Pharma. Oy
Company Description & information on cash position
09:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
09:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
FDA has approved Faron's Clevegen IND
16:00 FARN Faron Pharma. Oy
Faron�s financial calendar for 2020
14:00 FARN Faron Pharma. Oy
Holdings in Company
09:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:15 FARN Faron Pharma. Oy
Application to Nasdaq First North Growth Market
11:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
11:00 FARN Faron Pharma. Oy
Price Monitoring Extension
11:06 FARN Faron Pharma. Oy
Second Price Monitoring Extn
11:00 FARN Faron Pharma. Oy
Price Monitoring Extension
15:45 FARN Faron Pharma. Oy
Registration of Shares
07:00 FARN Faron Pharma. Oy
Results of Placing and Issue Price
16:51 FARN Faron Pharma. Oy
Proposed Placing and Financial Adviser Appointment
16:40 FARN Faron Pharma. Oy
Second Price Monitoring Extn
16:36 FARN Faron Pharma. Oy
Price Monitoring Extension
14:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
11:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
11:00 FARN Faron Pharma. Oy
Price Monitoring Extension
09:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
09:00 FARN Faron Pharma. Oy
Price Monitoring Extension
16:35 FARN Faron Pharma. Oy
Price Monitoring Extension
14:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
14:15 FARN Faron Pharma. Oy
Statement regarding Price Movement
14:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
11:06 FARN Faron Pharma. Oy
Second Price Monitoring Extn
11:00 FARN Faron Pharma. Oy
Price Monitoring Extension
16:35 FARN Faron Pharma. Oy
Price Monitoring Extension
09:27 FARN Faron Pharma. Oy
Results of EGM
14:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
Matins Trial Update
07:20 FARN Faron Pharma. Oy
Notice of EGM
07:00 FARN Faron Pharma. Oy
Update on Traumakine drug substance manufacturing
07:00 FARN Faron Pharma. Oy
MATINS poster presentation at ESMO Congress
09:13 FARN Faron Pharma. Oy
Holdings in Company
07:08 FARN Faron Pharma. Oy
Interim results
07:00 FARN Faron Pharma. Oy
MATINS study selected for ESMO 2019
07:00 FARN Faron Pharma. Oy
Result of Open Offer and Further Subscription
09:33 FARN Faron Pharma. Oy
Holding(s) in Company
07:00 FARN Faron Pharma. Oy
Notice of Interim Results
13:53 FARN Faron Pharma. Oy
Issue of Equity
07:00 FARN Faron Pharma. Oy
Subscription and Open Offer
07:00 FARN Faron Pharma. Oy
MATINS study update
09:00 FARN Faron Pharma. Oy
Price Monitoring Extension
16:40 FARN Faron Pharma. Oy
Second Price Monitoring Extn
16:35 FARN Faron Pharma. Oy
Price Monitoring Extension
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
09:31 FARN Faron Pharma. Oy
Holdings in Company
12:10 FARN Faron Pharma. Oy
Grant of options
07:00 FARN Faron Pharma. Oy
Phase II INFORAAA study update
07:00 FARN Faron Pharma. Oy
Final results from YODA study
12:27 FARN Faron Pharma. Oy
Results of AGM
09:32 FARN Faron Pharma. Oy
AGM update, Board & management changes
12:51 FARN Faron Pharma. Oy
Grant of Options
09:21 FARN Faron Pharma. Oy
Holding(s) in Company
09:16 FARN Faron Pharma. Oy
Holding(s) in Company
07:01 FARN Faron Pharma. Oy
Holdings in Company
07:00 FARN Faron Pharma. Oy
Share Subscription and Issue of Equity
07:05 FARN Faron Pharma. Oy
Notice of AGM
07:00 FARN Faron Pharma. Oy
Final Results for the year ended 31 December 2018
17:20 FARN Faron Pharma. Oy
Statement regarding Price Movement
14:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
Results from the Japanese Phase III study
16:09 FARN Faron Pharma. Oy
Holding(s) in Company
13:20 FARN Faron Pharma. Oy
Holding(s) in Company
07:00 FARN Faron Pharma. Oy
First expansion cohort for MATINS trial part 2
11:41 FARN Faron Pharma. Oy
Holding(s) in Company
07:00 FARN Faron Pharma. Oy
Notice of Results
09:23 FARN Faron Pharma. Oy
Holdings in Company
07:00 FARN Faron Pharma. Oy
Holding(s) in Company
12:54 FARN Faron Pharma. Oy
Results of the Placing and Subscription
15:31 FARN Faron Pharma. Oy
Result of Placing and Issue Price
07:00 FARN Faron Pharma. Oy
Proposed Placing to raise approximately EUR 3m
07:00 FARN Faron Pharma. Oy
MATINS study update
08:57 FARN Faron Pharma. Oy
New data published by Clinical Cancer Research
07:00 FARN Faron Pharma. Oy
Traumakine update - YODA results
11:20 FARN Faron Pharma. Oy
First patient dosed in phase I/II MATINS study
16:26 FARN Faron Pharma. Oy
Holding(s) in Company
07:00 FARN Faron Pharma. Oy
Patient subgroup identified from INTEREST trial
07:00 FARN Faron Pharma. Oy
Faron receives CTA approval for Clevegen
15:52 FARN Faron Pharma. Oy
PDMR Dealings
11:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
11:00 FARN Faron Pharma. Oy
Price Monitoring Extension
09:06 FARN Faron Pharma. Oy
Second Price Monitoring Extn
09:00 FARN Faron Pharma. Oy
Price Monitoring Extension
15:00 FARN Faron Pharma. Oy
INTEREST trial update presented at ESICM
09:23 FARN Faron Pharma. Oy
Director/PDMR Shareholding
07:00 FARN Faron Pharma. Oy
Faron announces CTA filing for Clevegen
07:00 FARN Faron Pharma. Oy
Interim Results
07:00 FARN Faron Pharma. Oy
New data published on Clever-1 function
11:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
11:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
Notice of Interim Results
08:45 FARN Faron Pharma. Oy
Holding(s) in Company
07:00 FARN Faron Pharma. Oy
Clevegen successful toxicity studies
07:00 FARN Faron Pharma. Oy
Holdings in Company
15:58 FARN Faron Pharma. Oy
Director/PDMR Shareholding
09:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:40 FARN Faron Pharma. Oy
Director/PDMR Shareholding
14:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
08:43 FARN Faron Pharma. Oy
Holding(s) in Company
15:42 FARN Faron Pharma. Oy
Holdings in Company
16:40 FARN Faron Pharma. Oy
Second Price Monitoring Extn
16:35 FARN Faron Pharma. Oy
Price Monitoring Extension
11:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
11:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
Biomarker analysis of Phase III INTEREST trial
14:33 FARN Faron Pharma. Oy
Result of AGM
07:00 FARN Faron Pharma. Oy
AGM Statement
07:00 FARN Faron Pharma. Oy
FDA approval of Faron's Traumakine� IND
07:00 FARN Faron Pharma. Oy
FDA grants Fast Track Designation for Traumakine�
07:00 FARN Faron Pharma. Oy
Faron Announces Clevegen Grant of European Patent
07:00 FARN Faron Pharma. Oy
Second Traumakine manufacturing site established
07:00 FARN Faron Pharma. Oy
Proposed Placing to raise up to £15m
07:00 FARN Faron Pharma. Oy
Faron hosts R&D Day today in London
15:31 FARN Faron Pharma. Oy
Results of Placing & Issue of Equity
13:37 FARN Faron Pharma. Oy
Issue of Equity
12:42 FARN Faron Pharma. Oy
Holdings in Company
12:41 FARN Faron Pharma. Oy
Holdings in Company
13:30 FARN Faron Pharma. Oy
Holding(s) in Company
13:25 FARN Faron Pharma. Oy
Holding(s) in Company
10:12 FARN Faron Pharma. Oy
Holding(s) in Company
12:54 FARN Faron Pharma. Oy
Holding(s) in Company
07:00 FARN Faron Pharma. Oy
Notice of Full Year Results
12:43 FARN Faron Pharma. Oy
Holdings in Company
07:00 FARN Faron Pharma. Oy
Final Results for the year ended 31 December 2017
09:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
09:00 FARN Faron Pharma. Oy
Price Monitoring Extension
07:00 FARN Faron Pharma. Oy
Top line data from the Phase III INTEREST trial
12:54 FARN Faron Pharma. Oy
Holdings in Company
16:40 FARN Faron Pharma. Oy
Second Price Monitoring Extn
16:35 FARN Faron Pharma. Oy
Price Monitoring Extension
10:05 FARN Faron Pharma. Oy
Notice of AGM
07:00 FARN Faron Pharma. Oy
Update on the Phase III INTEREST trial
13:34 FARN Faron Pharma. Oy
Holding(s) in Company
13:37 FARN Faron Pharma. Oy
Holding(s) in Company
16:51 FARN Faron Pharma. Oy
Holding(s) in Company
13:16 FARN Faron Pharma. Oy
Holdings in Company
14:05 FARN Faron Pharma. Oy
Second Price Monitoring Extn
14:00 FARN Faron Pharma. Oy
Price Monitoring Extension
15:14 FARN Faron Pharma. Oy
Director/PDMR Shareholding
17:53 FARN Faron Pharma. Oy
PDMR Shareholding